人間のNMDA受容体に対するケタミン作用の構造的基礎
Youyi Zhang1,2, Fei Ye3, Tongtong Zhang1,2
1Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Nature
|July 29, 2021
まとめ
抗うつ薬ケタミンの一番重要な成分であるS-ケタミンは,N-メチル-D-アスパルテート (NMDA) 受容体に結合する. 構造分析は特定の結合部位と相互作用を明らかにし,ケタミン基抗うつ薬の開発を導いています.
科学分野:
- 神経科学
- 構造生物学
- 薬理学について
背景:
- ケタミンは治療に抵抗する抗うつ剤です.
- ケタミンは,非競争的なN-メチル-D-アスパルテート (NMDA) 受容器チャネルブロッカーとして機能する.
- S-ケタミンはケタミンのより強力な抗うつ剤である.
研究 の 目的:
- S-ケタミンに結合する人間のNMDA受容体の冷凍電子顕微鏡構造を決定する.
- S-ケタミンとNMDA受容体の相互作用の構造的基礎を解明する.
- S-ケタミン結合と活性に関与する重要なアミノ酸残基を特定する.
主な方法:
- 凍結電子顕微鏡でNMDA受容体の構造を解析する.
- S-ケタミン,グリシン,グルタミン酸との複合形成.
- S-ケタミンの動きを分析する分子動力学シミュレーション
- 主要な残留物の機能を評価するためのサイト指向型変異.
主要な成果:
- S- ケタミンの結合ポケットは,NMDA受容体の中央前庭で特定されました.
- S- ケタミンは結合ポケット内の2つの異なる位置を占めていることが観察されました.
- 主要な残留物であるルシン642 (GluN2A/ 643 on GluN2B) とアスパラジン616 (GluN1) が特定されました.
- これらの残留物の変異は,NMDA受容体チャネルに対するケタミンの抑制効果を低下させた.
結論:
- S-ケタミンがヒトのNMDA受容体と結合し,それを抑制する方法に関する構造的洞察.
- S-ケタミンの抗うつ剤メカニズムに対する重要な相互作用の特定.
- ケタミンの抗うつ薬の改良を図るための基礎となる.
関連する概念動画
Parenteral Anesthetics: Overview
350
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
350
Local Anesthetics: Mechanism of Action
2.7K
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
2.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.1K
Antiepileptic Drugs: Glutamate Antagonists
607
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
607
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.3K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
654
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
654


